Phibro Animal Health Corporation (NASDAQ:PAHC) Announces Quarterly Dividend of $0.12

Phibro Animal Health Corporation (NASDAQ:PAHC) announced a quarterly dividend on Tuesday, May 5th. Investors of record on Wednesday, June 3rd will be given a dividend of 0.12 per share on Wednesday, June 24th. This represents a c) dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Wednesday, June 3rd.

Phibro Animal Health has a payout ratio of 23.9% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Phibro Animal Health to earn $3.28 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 14.6%.

Phibro Animal Health Stock Performance

Phibro Animal Health stock opened at $56.24 on Wednesday. The firm’s 50 day simple moving average is $53.93 and its 200 day simple moving average is $46.34. The company has a current ratio of 3.05, a quick ratio of 1.22 and a debt-to-equity ratio of 2.14. The firm has a market capitalization of $2.28 billion, a PE ratio of 25.00, a price-to-earnings-growth ratio of 0.84 and a beta of 0.61. Phibro Animal Health has a 1-year low of $18.89 and a 1-year high of $60.08.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, February 4th. The company reported $0.87 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.18. The business had revenue of $373.91 million for the quarter, compared to analyst estimates of $355.64 million. Phibro Animal Health had a net margin of 6.29% and a return on equity of 38.28%. As a group, analysts expect that Phibro Animal Health will post 3.03 earnings per share for the current fiscal year.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.